Tony Richa

Thomas Jefferson University

Papers

1

Total Citations

38

H-Index

1

About

Tony Richa is a leading surgical oncologist whose research centers on the intersection of human papillomavirus (HPV)-associated oropharyngeal cancer and treatment outcomes, with a particular focus on transoral robotic surgery (TORS). His most cited work, a 2020 study with 38 citations, critically examined how smoking history impacts disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) patients treated with TORS. This research challenged prevailing assumptions by demonstrating that smoking, while a known negative prognostic factor in nonsurgical chemoradiation, may not carry the same adverse implications when patients undergo robotic surgery—a finding that has helped refine patient selection and counseling for this emerging treatment modality. Richa’s contributions bridge the gap between surgical innovation and personalized risk stratification, offering clinicians evidence to better tailor therapies. His work underscores the importance of understanding how patient-specific factors like smoking interact with advanced surgical techniques, ultimately improving outcomes for a growing population of HPV-related cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Evaluating the impact of smoking on disease‐specific survival outcomes in patients with human papillomavirus–associated oropharyngeal cancer treated with transoral robotic surgery
38 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Thomas Jefferson University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago